mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |